AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

Cyproterone Acetate

12 registrations across 1 African market— 8 active

Markets with Cyproterone Acetate

🇿🇦South Africa
12 registrations
8 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
ANDROCUR 10 mg TABLETS🇿🇦South AfricaBayer (Pty) Ltd û IsandosuspendedSept 2025
ANDROFEM 100🇿🇦South AfricaCipla Medpro (Pty) LtdsuspendedJul 2025
CYPRENE-35 ED🇿🇦South AfricaPharmaplan (Pty) LtdsuspendedDec 2023
CYPROPLEX 50 mg🇿🇦South AfricaTeva Pharmaceuticals (Pty) LtdsuspendedFeb 2023
ANDROCUR 100 mg🇿🇦South AfricaPharmaco Distribution (Pty) LtdactiveAug 2001
ANDROCUR DEPOT🇿🇦South AfricaPharmaco Distribution (Pty) LtdactiveJan 1900
DIVA 35🇿🇦South AfricaUnicorn Pharmaceuticals (Pty) LtdactiveJan 1900
GINETTE🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
DIANE-35🇿🇦South AfricaBayer (Pty) Ltd û IsandoactiveJan 1900
CIPLA-CYPROTERONE ACETATE 50🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
ANDROFEM🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
ANDROCUR 50 mg TABLETS🇿🇦South AfricaPharmaco Distribution (Pty) LtdactiveJan 1900

Cyproterone Acetate in Africa — Regulatory Overview

Cyproterone Acetate is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 8 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.